HomeCompareSO vs SYK

SO vs SYK: Dividend Comparison 2026

SO yields 3.05% · SYK yields 1.04%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SYK wins by $20.6K in total portfolio value
10 years
SO
The Southern Company
● Live price
3.05%
Share price
$96.94
Annual div
$2.96
5Y div CAGR
7.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.7K
Annual income
$874.49
Full SO calculator →
SYK
SYK
● Live price
1.04%
Share price
$326.10
Annual div
$3.40
5Y div CAGR
46.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43.3K
Annual income
$8,282.98
Full SYK calculator →

Portfolio growth — SO vs SYK

📍 SYK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSOSYK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SO + SYK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SO pays
SYK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SO
Annual income on $10K today (after 15% tax)
$259.56/yr
After 10yr DRIP, annual income (after tax)
$743.32/yr
SYK
Annual income on $10K today (after 15% tax)
$88.62/yr
After 10yr DRIP, annual income (after tax)
$7,040.53/yr
At 15% tax rate, SYK beats the other by $6,297.22/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SO + SYK for your $10,000?

SO: 50%SYK: 50%
100% SYK50/50100% SO
Portfolio after 10yr
$33.0K
Annual income
$4,578.73/yr
Blended yield
13.88%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SYK right now

SO
Analyst Ratings
11
Buy
21
Hold
1
Sell
Consensus: Hold
Price Target
$98.25
+1.4% upside vs current
Range: $76.00 — $112.00
Altman Z
1.0
Piotroski
5/9
SYK
Analyst Ratings
1
Strong
35
Buy
14
Hold
Consensus: Buy
Price Target
$428.67
+31.5% upside vs current
Range: $390.00 — $469.00
Altman Z
4.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SO buys
13
SYK buys
0
PoliticianChamberTickerTypeAmountDate
Jared Moskowitz🏢 House$SO▲ Buy$1,001 - $15,0002025-12-02
Marjorie Taylor Greene🏢 House$SO▲ Buy$1,001 - $15,0002025-08-28
Jared Moskowitz🏢 House$SO▲ Buy$1,001 - $15,0002025-04-07
Marjorie Taylor Greene🏢 House$SO▲ Buy$1,001 - $15,0002025-04-03
Marjorie Taylor Greene🏢 House$SO▲ Buy$1,001 - $15,0002024-11-07
Valerie Hoyle🏢 House$SO▲ Buy$1,001 - $15,0002024-10-29
John James🏢 House$SO▼ Sell$1,001 - $15,0002024-09-04
Jared Moskowitz🏢 House$SO▲ Buy$1,001 - $15,0002024-07-05
Jared Moskowitz🏢 House$SO▲ Buy$1,001 - $15,0002024-07-05
Marjorie Taylor Greene🏢 House$SO▲ Buy$1,001 - $15,0002024-05-21
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSOSYK
Forward yield3.05%1.04%
Annual dividend / share$2.96$3.40
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR7.7%46.2%
Portfolio after 10y$22.7K$43.3K
Annual income after 10y$874.49$8,282.98
Total dividends collected$5.6K$21.0K
Payment frequencyquarterlyquarterly
SectorUtilitiesHealthcare
Analyst consensusHoldBuy
Analyst price target$98.25$428.67

Year-by-year: SO vs SYK ($10,000, DRIP)

YearSO PortfolioSO Income/yrSYK PortfolioSYK Income/yrGap
1← crossover$10,809$328.87$10,852$152.43$43.00SYK
2$11,693$365.31$11,838$226.03$145.00SYK
3$12,660$406.13$13,004$336.89$344.00SYK
4$13,720$451.89$14,420$505.63$700.00SYK
5$14,882$503.27$16,195$766.09$1.3KSYK
6$16,157$560.99$18,504$1,175.64$2.3KSYK
7$17,559$625.92$21,635$1,835.40$4.1KSYK
8$19,100$699.03$26,082$2,932.10$7.0KSYK
9$20,799$781.46$32,737$4,829.68$11.9KSYK
10$22,672$874.49$43,312$8,282.98$20.6KSYK

SO vs SYK: Complete Analysis 2026

SOUtilities

The Southern Company, through its subsidiaries, engages in the generation, transmission, and distribution of electricity. It operates through Gas Distribution Operations, Gas Pipeline Investments, Wholesale Gas Services, and Gas Marketing Services segments. The company also develops, constructs, acquires, owns, and manages power generation assets, including renewable energy projects and sells electricity in the wholesale market; and distributes natural gas in Illinois, Georgia, Virginia, and Tennessee, as well as provides gas marketing services, wholesale gas services, and gas pipeline investments operations. In addition, it owns and/or operates 30 hydroelectric generating stations, 24 fossil fuel generating stations, three nuclear generating stations, 13 combined cycle/cogeneration stations, 45 solar facilities, 15 wind facilities, one fuel cell facility, and four battery storage facility; and constructs, operates, and maintains 76,289 miles of natural gas pipelines and 14 storage facilities with total capacity of 157 Bcf to provide natural gas to residential, commercial, and industrial customers. The company serves approximately 8.7 million electric and gas utility customers. Further, the company offers digital wireless communications and fiber optics services. The Southern Company was incorporated in 1945 and is headquartered in Atlanta, Georgia.

Full SO Calculator →

SYKHealthcare

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Full SYK Calculator →
📬

Get this SO vs SYK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SO vs NEESO vs DUKSO vs DSO vs AEPSO vs EXCSO vs SCHDSO vs JEPISO vs O

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.